AAAAAA

   
Results: 1-9 |
Results: 9
Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia
Authors: Levin, MC Rosenblum, MK Fox, CH Jacobson, S
Citation: Mc. Levin et al., Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia, J NEUROVIRO, 7(1), 2001, pp. 61-65
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
Authors: Van Praag, RME Prins, JM Roos, MTL Schellekens, PTA Ten Berge, IJM Yong, SL Schuitemaker, H Eerenberg, AJM Jurriaans, S De Wolf, F Fox, CH Goudsmit, J Miedema, F Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226
Implementing a comprehensive relative-value-based incentive plan in an academic family medicine department
Authors: Cramer, JS Ramalingam, S Rosenthal, TC Fox, CH
Citation: Js. Cramer et al., Implementing a comprehensive relative-value-based incentive plan in an academic family medicine department, ACAD MED, 75(12), 2000, pp. 1159-1166
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor-sparing highly active antiretroviral therapy
Authors: Dybul, M Chun, TW Ward, DJ Hertogs, K Larder, B Fox, CH Orenstein, JM Baird, BF Li, YX Green, LG Engel, D Liu, SY Mican, JM Fauci, AS
Citation: M. Dybul et al., Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor-sparing highly active antiretroviral therapy, J INFEC DIS, 181(4), 2000, pp. 1273-1279
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
Authors: Rizzardi, GP De Boer, RJ Hoover, S Tambussi, G Chapuis, A Halkic, N Bart, PA Miller, V Staszewski, S Notermans, DW Perrin, L Fox, CH Lange, JMA Lazzarin, A Pantaleo, G
Citation: Gp. Rizzardi et al., Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA, J CLIN INV, 105(6), 2000, pp. 777-782
HIV eradication: Thinking the unthinkable
Authors: Fox, CH Cottler-Fox, M
Citation: Ch. Fox et M. Cottler-fox, HIV eradication: Thinking the unthinkable, J HUMAN VIR, 2(6), 1999, pp. 321-324
Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
Authors: Prins, JM Jurriaans, S van Praag, RME Blaak, H van Rij, R Schellekens, PTA ten Berge, IJM Yong, SL Fox, CH Roos, MTL de Wolf, F Goudsmit, J Schuitemaker, H Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410
An investigation of hypomagnesemia among ambulatory urban African Americans
Authors: Fox, CH Ramsoomair, D Mahoney, MC Carter, C Young, B Graham, R
Citation: Ch. Fox et al., An investigation of hypomagnesemia among ambulatory urban African Americans, J FAM PRACT, 48(8), 1999, pp. 636-639
Hot zones
Authors: Fox, CH
Citation: Ch. Fox, Hot zones, SCIENCE, 284(5412), 1999, pp. 262-263
Risultati: 1-9 |